-
Statement on offering COVID-19 vaccines to at-risk young people
firstwordpharma
July 20, 2021
Today’s advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) means more vulnerable young people at greatest risk from this virus can now benefit from COVID-19 vaccines.
-
China’s Kangtai Biological Partners With Startup to Develop mRNA Vaccines
firstwordpharma
July 20, 2021
Kangtai Biological Products said it plans to work with a biotech startup to develop vaccines based on mRNA technology, as reported Yicai Global on Monday.
-
Study shows why second dose of COVID-19 vaccine shouldn’t be skipped
firstwordpharma
July 20, 2021
The second dose of a COVID-19 vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine.
-
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
drugs
July 19, 2021
Giving a third dose of COVID-19 vaccines to immunocompromised adults will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week.
-
To Combat COVID-19 Vaccine Hesitancy in Black Community, Twin Sister Doctors Develop Strategy
prnewswire
July 19, 2021
As the nation continues to increase vaccination rates, Drs. Delana Wardlawand Elana McDonald, known as the Twin Sister Doctors, today released a special report offering insightful strategies to combat COVID-19 vaccine hesitancy.
-
SVMHS Helps Vaccinate Indigenous Population
prnewswire
July 19, 2021
As an increasing rate in COVID-19 cases causes concern, Salinas Valley Memorial Healthcare System (SVMHS) is using its Mobile Heath Clinic to deliver critical second vaccine doses to the rural community of Greenfield.
-
Many States Move to Ban Vaccine Mandates, Passports in Public Schools
drugs
July 16, 2021
As schools around America begin to prepare for reopening this fall, many states are taking steps to stop public schools from requiring COVID-19 vaccination or proof of vaccination.
-
48.3 Percent of U.S. ≥16s Have Had at Least One Dose of COVID-19 Vaccine
drugs
July 16, 2021
As of May 15, 2021, 48.3 percent of U.S. persons aged 16 years and older had received at least one COVID-19 vaccine dose, according to research published in the July 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality
-
Chilean Sinovac trial leaders recommend third dose of COVID-19 vaccine
firstwordpharma
July 16, 2021
The leaders of Chile’s late-stage human trial of Sinovac’s COVID-19 vaccine CoronaVac recommended a third dose of the shot, saying studies of participants showed their protecting antibody levels were lower after six months, as reported by Yahoo!News
-
Almost 100% of people have antibodies after second vaccine
firstwordpharma
July 16, 2021
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer and AstraZeneca vaccine.